Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Inzinger

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 20, 2014
[Peripheral streaks or leaf-like structures--that's the question]A Oliveira, M Inzinger, R Hofmann-Wellenhof
Journal of the European Academy of Dermatology and Venereology : JEADV|June 8, 2012
Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditionsM Inzinger, W Weger, B Heschl, et al.
The British Journal of Dermatology|February 24, 2015
Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditionsC Painsi, M Patscheider, M Inzinger, et al.
The British Journal of Dermatology|March 27, 2014
Short- to intermediate-term follow-up in patients treated with the combination of 311-nm ultraviolet B phototherapy and biological agentsM Inzinger, F J Legat, A Hofer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 18, 2013
UV-induced alterations of the skin evaluated over time by reflectance confocal microscopyS Koller, M Inzinger, M Rothmund, et al.
The British Journal of Dermatology|September 14, 2011
Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trialP Wolf, W Weger, F J Legat, et al.
The British Journal of Dermatology|May 14, 2011
Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registryM Inzinger, B Heschl, W Weger, et al.
The British Journal of Dermatology|December 8, 2020
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysisT Graier, W Salmhofer, C Jonak, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 20, 2014
[Peripheral streaks or leaf-like structures--that's the question]A Oliveira, M Inzinger, R Hofmann-Wellenhof
Journal of the European Academy of Dermatology and Venereology : JEADV|June 8, 2012
Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditionsM Inzinger, W Weger, B Heschl, et al.
The British Journal of Dermatology|February 24, 2015
Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditionsC Painsi, M Patscheider, M Inzinger, et al.
The British Journal of Dermatology|March 27, 2014
Short- to intermediate-term follow-up in patients treated with the combination of 311-nm ultraviolet B phototherapy and biological agentsM Inzinger, F J Legat, A Hofer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 18, 2013
UV-induced alterations of the skin evaluated over time by reflectance confocal microscopyS Koller, M Inzinger, M Rothmund, et al.
The British Journal of Dermatology|September 14, 2011
Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trialP Wolf, W Weger, F J Legat, et al.
The British Journal of Dermatology|May 14, 2011
Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registryM Inzinger, B Heschl, W Weger, et al.
The British Journal of Dermatology|December 8, 2020
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysisT Graier, W Salmhofer, C Jonak, et al.
Pageof 1